Anti-Human CD274 Recombinant Antibody (TAB-417CQ)
Recombinant monoclonal antibody to CD274. This antibody is a human IgG1 monoclonal antibody that targets and binds to PD-L1, a protein that is often overexpressed on the surface of cancer cells and immune cells in the tumor microenvironment.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Recombinant monoclonal antibody to CD274. This antibody is a human IgG1 monoclonal antibody that targets and binds to PD-L1, a protein that is often overexpressed on the surface of cancer cells and immune cells in the tumor microenvironment. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Anti-Human CD274 Recombinant Antibody (TAB-417CQ)
- abbr: Anti-Human CD274 Recombinant Antibody (TAB-417CQ)
- Target: CD274
- Host Animal: Human
- Specificity: Human CD274
- Immunogen: The details of the immunogen for this antibody are not available.
Relevant Applications
- ELISA
- IHC
- FC
- IP
- IF
- Inhib
- FuncS
- The CD274 antibody has been reported in applications of ELISA
